Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)
单位：[1]Sahlgrenska University Hospital, Gothenburg, Sweden[2]LungenClinic Grosshansdorf and Christian-Albrechts University Kiel, Airway Research Center North, Member of the German Center for Lung Research (DZL), Kiel, Germany[3]Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, United States of America[4]Pulmonary Research Institute of Southeast Michigan, Farmington Hills, United States of America[5]National Clinical Research Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[6]Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan[7]Pearl – A member of the AstraZeneca Group, Durham, United States of America[8]Pearl – A member of the AstraZeneca Group, Morristown, United States of America[9]AstraZeneca Gothenburg, Mölndal, Sweden[10]Pearl – A member of the AstraZeneca Group Gothenburg, Durham, United States of America[11]Pearl – A member of the AstraZeneca Group and AstraZeneca, Morristown, United States of America
第一作者单位：[1]Sahlgrenska University Hospital, Gothenburg, Sweden
推荐引用方式(GB/T 7714)：
Leonardo Michele Fabbri,Klaus F. Rabe,Fernando J. Martinez,et al.Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)[J].EUROPEAN RESPIRATORY JOURNAL.2018,52:doi:10.1183/13993003.congress-2018.PA688.
APA：
Leonardo Michele Fabbri,Klaus F. Rabe,Fernando J. Martinez,Gary T. Ferguson,Chen Wang...&Colin Reisner.(2018).Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis).EUROPEAN RESPIRATORY JOURNAL,52,
MLA：
Leonardo Michele Fabbri,et al."Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)".EUROPEAN RESPIRATORY JOURNAL 52.(2018)
医学